Evidence map›Paper›PMID 37052589›Full record

ArticleMicrobial genomics2023

Single nucleotide variants in

Morteza M Saber, Jannik Donner, Inès Levade, Nicole Acosta, Michael D Parkins, Brian Boyle, Roger C Levesque, Dao Nguyen, B Jesse Shapiro

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Distinct Effects ofMicroorganisms · 2025
    Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Morteza M SaberDepartment of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
Jannik DonnerDepartment of Medicine, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Inès LevadeDepartment of Medicine, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Nicole AcostaDepartment of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, AB, Canada.
Michael D ParkinsDepartment of Microbiology, Immunology and Infectious Disease, University of Calgary, Calgary, AB, Canada.
Brian BoyleIntegrative Systems Biology Institute, University of Laval, Québec, QC, Canada.
Roger C LevesqueIntegrative Systems Biology Institute, University of Laval, Québec, QC, Canada.
Dao NguyenDepartment of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
B Jesse ShapiroDepartment of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
McGill University Health Centre · CAUniversité Laval · CAUniversity of Calgary · CAMcGill Genome Centre · CAMcGill University · CA

Funding

CIHR PJT-148827
6 · The paper itself

Abstract

The severity and progression of lung disease are highly variable across individuals with cystic fibrosis (CF) and are imperfectly predicted by mutations in the human gene CFTR, lung microbiome variation or other clinical factors. The opportunistic pathogen

Indexed as

Cystic FibrosisPseudomonas InfectionsAdultDisease ProgressionHumansLungNucleotidesPseudomonas aeruginosaNucleotidesAmpliSeqcystic fibrosisgenomicslung functionmachine learningPseudomonas aeruginosawithin–host diversity

Identifiers

PMID37052589
PMCPMC10210962
OpenAlexW4365443776

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.